Related Experiment Videos

Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides

T P Stauffer1, C H Martenson, J E Rider

  • 1Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, 27710, USA.

Biochemistry
|August 5, 1997
PubMed

Insights

Proline-rich peptides targeting the Lyn SH3 domain block IgE receptor-mediated mast cell activation by inhibiting FcepsilonRI phosphorylation and calcium signaling.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Lyn tyrosine kinase is crucial for IgE receptor (FcepsilonRI)-mediated mast cell activation.
  • The precise mechanism of Lyn activation remains unclear.

Purpose of the Study:

  • To investigate the mechanism of Lyn activation in mast cells.
  • To identify specific molecular interactions that regulate FcepsilonRI signaling.

Main Methods:

  • Utilized micro-electroporation to introduce peptides into mast cells.
  • Employed phage display to derive peptides with specific binding to Lyn SH3 domains.
  • Monitored calcium signaling and Syk translocation in response to FcepsilonRI stimulation.

Main Results:

  • Proline-rich peptides binding to Src family SH3 domains inhibited calcium spikes in a dose-dependent manner.
  • Peptides with enhanced Lyn SH3 specificity blocked FcepsilonRI-mediated calcium signaling at relevant concentrations.
  • SH3 binding peptides prevented Syk translocation, indicating a block in FcepsilonRI phosphorylation.

Conclusions:

  • Peptide binding to the Lyn SH3 domain suppresses Lyn-mediated FcepsilonRI phosphorylation.
  • This suppression inhibits downstream calcium signaling in mast cells.
  • Identified a potential therapeutic target for modulating mast cell activation.

Related Concept Videos